Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Systemic iron overload presents significant challenges in acute myeloid leukemia (AML) management.
• Iron overload impacts patient quality of life and overall survival.
• The precise roles and mechanisms of iron overload in leukemia initiation and progression are not fully understood.

Purpose of the Study:

• To investigate the correlation between iron overload and AML clinical outcomes.
• To explore the pathophysiological mechanisms by which iron overload influences AML progression.

Main Methods:

• Utilized two distinct mouse models: an iron overload MLL-AF9-induced AML model and a nude xenograft model.
• Analyzed ferritin levels in AML patients, correlating iron expression with prognosis and survival.
• Investigated the impact of iron overload on leukemia cell proliferation and tumor burden in bone marrow and extramedullary tissues.

Main Results:

• AML patients, especially those with myelomonocytic (M4) or monocytic (M5) subtypes, exhibited elevated ferritin levels.
• Higher iron expression levels correlated with poorer prognosis and reduced survival in both AML patients and mice.
• Iron overload exacerbated tumor load by promoting leukemia cell proliferation via FOS upregulation.

Conclusions:

• Iron overload plays a significant role in the progression of acute myeloid leukemia.
• Findings suggest iron overload as a potential therapeutic target for improving AML patient outcomes.
• This study provides a rationale for evaluating iron chelation therapy in AML treatment strategies.